Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immatics Biotech begins phase III IMA-901 trial in renal cell carcinoma

Dec. 31, 2010

Medimmune begins phase Ib/II trial of MEDI-575 in NSCLC

Dec. 31, 2010

BioCancell Therapeutics completes preclinical studies of BC-821 for glioblastoma

Dec. 31, 2010

HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Bristol-Myers Squibb and Otsuka to copromote Sprycel in Japan

Dec. 30, 2010

Phase I/II trial of belinostat/Tarceva combination in NSCLC advances

Dec. 30, 2010

Ziopharm Oncology treats first patient in phase I trial of palifosfamide

Dec. 30, 2010

New inhibitors of focal adhesion kinase 1 claimed

Dec. 30, 2010

MK-0752 shows promise in patients with breast cancer

Dec. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.